Espin MT Tablet ER is a combination medication containing Amlodipine 2.5mg and Metoprolol Succinate 50mg, designed for the effective management of hypertension and angina pectoris. Amlodipine, a calcium channel blocker, works by relaxing blood vessels, thereby improving blood flow and reducing blood pressure. Metoprolol Succinate, a beta-1 selective beta-blocker, helps to decrease heart rate, cardiac output, and myocardial oxygen demand, which aids in controlling high blood pressure and preventing chest pain. The extended-release formulation ensures a steady release of the active ingredients, promoting consistent therapeutic effects and enhancing patient compliance by allowing once-daily dosing. Espin MT Tablet ER is particularly beneficial for patients requiring dual therapy to achieve optimal cardiovascular control. It is important to take this medication exactly as prescribed by a healthcare professional, and patients should inform their doctor about any pre-existing conditions such as asthma, diabetes, or heart block. Common side effects may include dizziness, fatigue, or swelling of the ankles. Regular monitoring of blood pressure and heart rate is recommended during treatment. Espin MT Tablet ER should not be discontinued abruptly to avoid adverse cardiovascular events.